Gilead Sciences has agreed to purchase the remainder of improvement accomplice Arcellx in a deal that values the biotechnology firm at about $7.8 billion at closing.
Source link
Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion
Related Posts
Opinion | Time-Traveling Through 35mm Film
Analog pictures fosters a spontaneity uncommon within the digital period. Source link
Blackstone Leads $400 Million Investment in Cyber Startup Cyera
The funding values the corporate at $9 billion as investor curiosity in cybersecurity startups grows. Source link
Telecom Heavyweights Circle Wagons Around Cybersecurity
Main telecom suppliers are launching a cybersecurity alliance to enhance real-time risk sharing and strengthen defenses towards escalating assaults on…